SCHEMBL668703

SCHEMBL668703

NS(=O)(=O)CCNC(=O)c1ccccc1

nearest known ligand 0.66

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.59
GAA P10253 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.54
LMNA P02545 1/20 0.54
POLB P06746 1/20 0.54
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
EPHX2 P34913 1/20 0.53
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
PRSS1 P07477 1/20 0.53
CTSG P08311 1/20 0.53
CTRB1 P17538 1/20 0.53
CMA1 P23946 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5709109 0.84 L3MBTL1 (0.60) L3MBTL1GAASMN1; SMN2LMNAPOLB
SCHEMBL28284128 0.83 CA1 (0.59) GAACA1CA2NPC1RAB9A
SCHEMBL4564262 0.82 L3MBTL1 (0.59) L3MBTL1GAASMN1; SMN2LMNAPOLB
SCHEMBL10248310 0.82 HPGDS (0.59) L3MBTL1SMN1; SMN2CA1CA2MEN1
SCHEMBL11343355 0.81 MAPT (0.66) L3MBTL1GAASMN1; SMN2LMNAPOLB
SCHEMBL3192014 0.80 LMNA (0.77) GAASMN1; SMN2LMNAPOLBCA1
SCHEMBL10035679 0.78 HPGD (0.56) L3MBTL1SMN1; SMN2LMNAPOLBNPC1
SCHEMBL10624683 0.78 L3MBTL1 (0.55) L3MBTL1GAASMN1; SMN2LMNAPOLB
SCHEMBL2168052 0.77 HDAC1 (0.63) L3MBTL1GAASMN1; SMN2LMNAPOLB
SCHEMBL731620 0.77 CYP1A2 (0.67) GAASMN1; SMN2LMNAPOLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2606038-A1 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C Bristol-Myers Squibb Company (US) 2013-06-26 EP disclosed
WO-2012024373-A1 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C BRISTOL-MYERS SQUIBB COMPANY (US) 2012-02-23 WO disclosed